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Abstract.  Thrombospondin (TSP) contains the Arg- 
Gly-Asp (RGD) sequence that is thought to be impor- 
tant for cell adhesion mediated by several cell-surface 
integrin  receptors.  The RGD sequence is located in 
the type 3 repeat region of TSP that has multiple Ca  2+ 
binding sites and is subject to a complex intramolecu- 
lar thiol-disulfide isomerization.  TSP that we isolated 
from thrombin-activated human platelets using buffers 
containing  0.1  mM Ca  2§  in which Cys  TM is the major 
labeled cysteine, did not have RGD-inhibitable adhe- 
sive activity.  However, one of our preparations  of TSP 
and TSP purified following alternative procedures using 
>10.3 mM Ca  2§ did have RGD-inhibitable adhesive ac- 
tivity. Reduction of TSP with DTT, either before or 
after adsorption to surfaces, enhanced its adhesive ac- 
tivity. Reduced TSP supported robust cell spreading 
when coated at concentrations as low as  1 #g/ml, 
whereas "adhesive" TSP not treated with DTT was ac- 
tive at coating concentration of > 20 #g/ml and sup- 
ported only modest cell spreading.  Lower DTT concen- 
trations were required for enhancement of the adhesive 
activity of TSP if Ca  2+ was chelated with EDTA.  Cel- 
lular adhesion to DTT-treated TSP was inhibited by 
RGD-containing peptide and by mAb to a  functional 
site of the av/$3 integrin.  Cell blots of reduced proteo- 
lytic fragments of TSP localized the adhesive activity 
to the RGD-containing type 3 repeat region.  These re- 
suits suggest a novel mechanism for regulation of in- 
tegrin-ligand  interactions  in which the ligand can 
isomerize between inactive and active forms. 
T 
hE  originally  described  form  of  thrombospondin 
(TSP) ~  is a major glycoprotein of platelet a-granules 
released upon platelet activation and a major secreted 
product of many cultured cells (Mosher,  1990).  According 
to Dr. Vishva Dixit (personal communication), platelet TSP 
is exclusively TSP1 when analyzed by isoform-specific  anti- 
bodies. However,  we call TSP purified from platelets  just 
"TSP: Recently, another closely related but clearly distinct 
TSE termed TSP2, was identified  from mouse and chicken 
cDNA libraries  (Bomstein et al.,  1991a,b;  Lawler et al., 
1991).  Both TSP and  TSP2  contain the cell adhesion se- 
quence Arg-Gly-Asp (RGD) (Lawler and Hynes, 1986; Law- 
ler et al., 1991). A number of RGD-containing  extracellular 
proteins,  such as vitronectin,  fibronectin,  and fibrinogen, 
unambiguously promote cell  adhesion  when  coated onto 
substrata in a process mediated by cell surface integrin  re- 
ceptors (Ruoslahti  and Pierschbacher,  1987). The adhesive 
activity of TSP, however,  is  more complicated.  Different 
groups have tested TSP purified from platelet releasate  for 
adhesive activity on various cells with contradictory and 
controversial  results. 
Opposite results have been observed for the same cell type. 
1. Abbreviations used in this paper; BAE, bovine aorta endothelial; HBS, 
Hepes buffered saline; RGD, Arg-Gly-Asp;  TSP, thrombospondin purified 
from platelets. 
Lahav  (1988a)  reported that  TSP inhibits  endothelial  cell 
adhesion,  while others found that TSP promotes endothelial 
cell  adhesion  (Lawler  et  al.,  1988;  Murphy-UUrich  and 
H66k,  1989; Taraboletti  et al.,  1990).  Lahav  (1988b) also 
reported  that  TSP  inhibits  platelet  adhesion,  whereas 
Tuszynski et al.  (1987) and Tuszynski and Kowalska (1991) 
found that  TSP supports platelet adhesion. 
Among the pro-adhesion papers, the proposed cell surface 
receptors that mediate cell adhesion to TSP-coated substrate 
are many. Candidates  include the GPITo/IIIa (t~rd~3) (Tus- 
zynski et al., 1989; Karczewski et al., 1989) and vitronectin 
receptor (av/$3) (Lawler et al.,  1988;  Lawler and Hynes, 
1989; Tuszynski et al.,  1989) integrins.  Candidates  also in- 
clude heparan  sulfate  proteoglycan (Roberts et al.,  1987; 
Kaesberg et al.,  1989), GPIV (also known as CD36) (Asch 
et al.,  1991), and unidentified  receptors that recognize  the 
carboxyl-terminal region (Roberts et al.,  1987; Kosfeld et 
al.,  1991) or the type 1 repeat (Prater et al.,  1991) of TSP. 
For adhesion of C32 human melanoma cells to TSP-coated 
substrate,  Tuszynski et al. (1989) proposed that the adhesion 
is mediated by GPllb/llIa-like  vitronectin  receptor,  inas- 
much as the adhesion was sensitive to RGD-containing  pep- 
tide and polyclonal antibodies against  GPllb/IIIa or vitro- 
nectin receptor.  Asch et al. (1991), in contrast, proposed that 
the adhesion ofC32 cells to TSP is mediated by the combina- 
tion  of heparan  sulfate  proteoglycan and  GPIV,  because 
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hibited the adhesion. 
Even for the same cell type adhering to TSP by the same 
presumptive receptor, different results have been obtained. 
Lawler et al. (1988)  found that TSP supported endothelial 
cell attachment but not spreading and that the cell attach- 
ment was blocked by RGD-containing peptide.  Since the 
adhesion activity was lost if dishes were coated with TSP in 
the presence of EGTA and could not be restored by addition 
of Ca  2§ in the cell adhesion assay, Lawler et al. (1988) con- 
eluded that exposure of the RGD sequence of TSP is depen- 
dent on Ca  ~+. Taraboletti et al. (1990) did not control [Ca  2+] 
and observed that TSP strongly supported endothelial cell 
spreading  as  well  as  attachment and  that  RGD  peptide 
mainly inhibited cell spreading rather than cell attachment. 
We have attempted to reconcile some of these discrepan- 
cies. Most of our TSP preparations did not support RGD- 
inhibitable cell adhesion.  Reduction of nonadhesive TSP 
with DTT substantially enhanced its adhesive activity. The 
cell adhesion to  DTT-treated TSP  was blocked by RGD- 
containing peptide and mAb LM609 to the t~vfl3 vitronectin 
receptor. These results suggest that exposure of the RGD se- 
quence in TSP is controlled by disulfides and are discussed 
in the context of a loop-(loop)-/~-turn motif  proposed for the 
Ca2§  type 3 repeat region of TSP in which the RGD 
sequence is imbedded. 
Materials and Methods 
Standard Purification of  Platelet TSP 
The purification procedure for TSP that has been standard in our lab over 
the past 8 yr (Murphy-Ullrich and Mosher, 1985) is as follows. 8 U of 1-d- 
old platelet concentrates are obtained from the Badger Red Cross (Madison, 
WI) and washed three times with Hepes buffer containing 0.05 M Hepes, 
0.15 M NaCI, and 10% of acid citrate dextrose (ACD) to give a final concen- 
tration  of  0.017 M  citrate/citric  acid,  pH  7.6. Washed  platelets  are 
resuspended in 50 ml of resuspension buffer (0.1 M Hepes, 0.15 M NaCI, 
5 mM dextrose,  pH 7.6) and activated with 1 U/ml thrombin in 37~  water 
bath for 2 rain with stirring. The [Ca  2+] in the released products (platelet 
releasate), determined with an ion-selective electrode, was 2.6 +  1.0 mM 
(n =  4). Thrombin is inactivated with nitrophenyl  p-guanidine benzoate at 
a final concentration of 1 mM. The reaction mixture is immediately ice- 
cooled and centrifuged at 20,000 g at 4"C. The supernatant is snap-frozen 
and kept at -70~  overnight. After thawing at 37~  and centrifugation to 
remove the small fibrin clot derived from platelet fibrinogen, the superna- 
tant is applied to a heparin-agarose (Sigma Chemical Co., St. Louis, MO) 
column. The column is washed with TBS (0.01 M Tris-HCl, 0.15 M NaC1, 
pH 7.6) and eluted with 0.55 M NaCI buffered with Tris-HCl. Both washing 
and elution buffers contain 0.1 mM Ca  2+. The peak fractions,  as monitored 
by absorption at 280 rim, are pooled and applied to a gel-filtration  (model 
P-300; Bio-Rad  Laboratories, Cambridge, MA) column equilibrated and 
eluted with TBS containing 0.1 mM Ca  2+. The peak at Vo is collected as 
purified TSP. Both chromatographic steps are performed at room tempera- 
ture on the same day immediately after thawing.  Aliquots of each prepara- 
tion are snap-frozen and stored at -70~  The yield is typically 0.6-1 mg 
TSP/unit of platelet or 4-8 rag/preparation. 
Mapping of Free Thiols in Our Purified TSP 
TSP, 12 trig pooled from several preparations, was lyophilized,  dissolved 
in 15 mi of 8 M urea, 0.3 M Tris, pH 8, and incubated with 30/~Ci 2-[~4Cl  - 
iodoacetic  acid at 200C for 1 h and then with 80 mg unlabeled iodoacetic 
acid at 20~  for 1 h. The reaction mixture was dialyzed against 0.05 M Tris 
buffer containing 8 M  urea, pH 8.3, reduced with 10 nag dithioerythritol 
at 20"C for 0.5 h, and carboxymethylated by adding a surplus of unlabeled 
iodoacetic  acid at 200C for 0.5 h. The derived protein was dialyzed against 
0.1 M  NI-I4HCO3 and then digested with chymotrypsin at a  1:50 (wt/wt) 
enzyme to substrate ratio at 37~  for 60 h. The peptides were chromato- 
graphed by HPLC on a VYDAC C~s 5-gin column (0.8  x  24 cm) with a 
linear ethanol gradient, with solution A being 0.1% trifluoroacetic  acid and 
solution B being 96 % ethanol. The single peak that contained the radiolabel 
was further chromatographed on a Nncleosil Cls 7-#m column (0.4  x  24 
cm) with the same gradient. The radioactive peptide was sequenced on a 
sequencer (model 470A; Applied Biosystems,  Inc., Foster City, CA) after 
lyophilization. 
Alternative Purifications of Platelet TSP 
The procedure of Lawler et al. (1985) was carried out with modifications. 
8 U of platelets were washed twice with pH 6.5 buffer containing 0.102 M 
NaCl, 3.9 mM K2HPO4, 3.9 mM Na2HPO4, 22 mM NaH2PO4, and 5.5 
mM glucose. The platelets were resuspended in 100 rnl ofpH 7.6 buffer con- 
taining 0.015 M Tris, 0.14 M NaCI, 5 mM glucose,  and 2 mM Ca2+; acti- 
vated with 1 U/ml of thrombin at 22~  for 2 min with stirring; and cen- 
trifuged in a  swinging  bucket centrifuge for 0.5  rain at  1,000  g.  The 
supernatant was treated with diisopropyl  fluorophosphate at a final concen- 
tration of 1 mM to inactivate thrombin, and further centrifuged at 50000 g 
for 40 rain at O~  The supernatant was kept at 0~  overnight, and cen- 
trifuged to remove the small fibrin clot before application to a column of 
heparin-Sepharose CL-6B (Pharmacia Fine Chemicals, Piscataway, NJ) at 
4~  Stepwise elution was carried out with 0.15, 0.25, 0.55, and 2.0 M NaC1 
in 0.015 M  Tris, 0.02%  NAN3, 2 mM CaC12, pH 7.6. The peak fractions 
from the 0.55 M NaCI peak were pooled and applied to gel-filtration column 
(model P-300; Bio-Rad Laboratories) at 4~  equilibrated and elnted with 
TBS containing 2 mM Ca  2+. The peak at Iio was collected as purified TSP. 
The yields were low, largely due to loss on the heparin-Sepharose column. 
Less than 0.1 mg TSP/unit of platelet were obtained with a concentration 
lower than 100 #g/ml.  Lawler,  in contrast, usually obtains 0.2-0.4  mg 
TSP/unit of platelets (J. Lawler,  personal communication). 
As a third purification scheme, our routine purification (described above) 
was altered so that 0.3 mM Ca  2+ was included in all buffers rather than 0A 
mM Ca  2+. The yields were similar to those obtained with 0.1 mM Ca  2+. 
Other Adhesive Proteins 
Fibronectin, fibrinogen, and vitronectin were purified as previously  de- 
scribed (Mosher and Johnson, 1983; Mosher and Blont, 1973; and Dahl- 
b/ick and Podack,  1985). 
Preparation of TSP-coated Wells 
TSP was diluted to indicated concentrations with buffer containing 10 mM 
Hepes (pH 7.2),  0.135 M NaCI, 3 mM KCI, 0.5 mM MgCI2 (HBS) plus 
1 mM CaC12 (HBS/Ca  2+) or 1 mM EGTA, and added to a 24-well bacteri- 
ologic culture dish (Falcon 8111, Becton Dickinson Labware, Lincoln Park, 
NJ), 0.3 rni/well.  The dish was incubated at 37~  for 1-1.5 h, unless other- 
wise indicated, and washed three times with HBS/Ca  ~+ or HBS as indi- 
cated before the cell suspension was added. 
Preparation of Wells Coated with Reduced TSP 
Two protocols were used.  In one, TSP was diluted with buffer containing 
no DTT, added to wells, and incubated at 37~  for 1-1.5 h. After removing 
the coating buffer, the wells were incubated at room temperature for 30 min 
with buffer containing DTT and Ca  2+ or EDTA. Alternatively,  TSP was re- 
duced before coating by addition of DTT to TSP in I-IBS containing 2 mM 
Ca  2+ or EDTA. After incubation at room temperature for 30 min, the mix- 
ture was added to wells and incubated at 4~  overnight. 
All the wells were washed three times with HBS/Ca  2+ or HBS before the 
cell suspension was added. 
A number  of other proteins were tested to learn whether the enhancement 
of adhesion upon reduction is a specific property of TSP: bovine albumin 
(BSA), ovalbumin, goat IgG, and human z-globulins from Sigma Chemical 
Co.; bovine thrombin from Gen Trac Inc. (Middleton, WI); and high mo- 
lecular weight kininogen, antithrombin  III, histidine-rich  glycoprotein,  and 
amino-terminal 70-kD fragment of fibronectin purified in our laboratory. 
These proteins were coated at 10 gg/ml and then treated with 20 mM DTT 
as was done with TSP. 
Cell Adhesion Assay 
Nearly or freshly confluent bovine aorta endothelial (BAE) cells (Murphy- 
Ullrich and Mosher, 1987) between passage 5 and 13 were removed from 
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sin/EDTA) ratio at 37~  (Lawler et al.,  1988; Murphy-Ullrich and HOfk, 
1989). Trypsin was inactivated  by addition of soybean trypsin inhibitor. Af- 
ter washing once with I-IBS/Ca  2+, the cells were resuspended in I-IBS/Ca  2+ 
containing 0.2% BSA, which had been inactivated by heating to 70~  for 
1 h, and incubated in TSP-coated  wells at 37~  for 1.5 h (Lawler et al., 
1988). In some experiments, Gly-Arg-Gly-Asp-Ser (GRGDS) (Biotechnol- 
ogy Center, University of Wisconsin) or Arg-Gly-Glu-Ser (RGES) (Peptide/ 
Oligonucleotide  Facility,  University of California-San Diego,  a kind gift 
from Dr. B. L. Allen-Hoffmaun, University of Wisconsin) or LM609 mAb 
(a kind gift from Dr.  David Cheresh, Scripps Clinic, La Jolla, CA) was 
added at the beginning of the incubation. After incubation, the wells were 
washed three times with HBS/Ca  2+, and the attached cells were fixed with 
4 % paraformaidehyde,  stained with amido black, and counted under a mi- 
croscope. To avoid bias, a 1.4-ram-wide strip on each well along its diameter 
(1.5 cm) was counted (total area of 21 mm2). Cells did not attach to non- 
precoated wells. 
Adhesion assays were also done with C32 human melanoma cells, U937 
human monocyte cells, and NRK cells, all obtained from the American 
Type Culture Collection (Rockville,  MD). 
Cell Blotting of TSP and Its Fragments on 
Nitrocellulose Paper 
Thrombin digestion of TSP was performed with 4 U/nil thrombin (a kind 
gift from Dr. John Fenton, New York State Department of Health, Albany, 
NY) and 2 mM EDTA at room temperature for 20 h. Trypsin digestion was 
either with 1:20 (wt/wt) TPCK-trypsin (Sigma Chemical Co.) and 2 mM 
EDTA at 0*C for 20 h, or with 1:5 (wt/wt) trypsin and 2 mM Ca  2+ at 0*C 
for 24 h. Chymotrypsin digestion was either with 1:30 (wt/wt) chymotryp- 
sin (Sigma Chemical Co.) and 2 mM EDTA at 37~  for 20 rain, or with 
1:5000 (wt/wt) chymotrypsin and 2 mM EDTA at 0~  for 32 h. The diges- 
tions were  stopped by  addition of reducing sample buffer for sodium 
dodecyl  sulfate  polyacrylamide  gel  electrophoresis  (SDS-PAGE)  and 
heated. 
Cell blotting was performed following a previously published procedure 
(Hayman et al.,  1982) with modifications.  Briefly, TSP (4/~g/weil) or its 
protease digestion mixtures (8  /~g/well) were  electrophoresed by  SDS- 
PAGE. The proteins were electrophoreticaUy  transferred to nitrocellulose 
paper (Schleicher & Schueil, Keene, NH) in a Tris-glycine transfer buffer 
containing 10% methanol. The transferred nitrocellulose paper was stained 
with ponceau S (Harlow and Lane, 1988) to visualize and mark the protein 
bands. The paper was then incubated with 0.5%  BSA at 37~  for at least 
30 rain to block the surface. BAE cell suspensions (8 X 105 cells/nil, gener- 
ated as in cell adhesion assay)  were carefully layered  on the paper ("~1 
mlll0-cm  2 paper) spread on a  flat parafilm surface.  After incubation at 
37~  for 1 h, the paper was washed three times with I-IBS/Ca  z+ to remove 
nonadherent cells. The paper-adherent cells were fixed with paraformalde- 
hyde, stained with 1:5 diluted trypan blue (Gibco Laboratories, Grand Is- 
land, NY) for 15 rain, briefly destained with H20, and air dried. The paper 
was examined under a microscope to insure that staining was due to the ad- 
herent cells.  Duplicate sample sets were directly stained with amido black 
after transfer to nitrocellulose paper to give a permanent record of trans- 
ferred proteins or immunoblotted with MA-1 mAb (a kind gift from Dr. J. 
Lawler,  Harvard Medical School,  Boston, MA). 
Reduction and Carboxymethylation of TSP 
TSP was treated with 2 mM Ca  2+ or 2 mM EDTA for 10 min. DTT was 
added to final concentrations of 0, 0.2, 0.6, 2, 6, or 20 mM. The samples 
were incubated for t h under argon gas. Iodoacetamide (Sigma), 0.5 M in 
TBS, was added to a final concentration of 50 mM with a final pH >8. The 
samples were incubated in the dark for 3 h under argon gas. The procedures 
were performed at room temperature. The samples were divided into two 
atiquots, dialyzed at 4~  either against TBS with 2 mM Ca  2+ (for DTT + 
Ca2+-treated  samples) or TBS  (for DTT  +  EDTA-treated  samples) for 
SDS-PAGE and cell adhesion studies,  or against 1% acetic acid followed 
by lyophilization  for amino acid analysis. 
Amino Acid Analysis 
Amino acid analysis was performed as previously described (Ohlin and 
Stenflo,  1987) on a Beckman 6300 amino acid analyzer. 
Results 
Different Preparations of  Platelet TSP Have Different 
Adhesive Activities 
Seven of the eight preparations of our standard TSP did not 
have adhesive activity for trypsinized cells when coated on 
nontissue  culture  dishes.  One  preparation  of  our  TSP 
(BR220), however, did support adhesion of C32, NRK, and 
BAE cells, but not of U937 cells. Cell adhesion was sensitive 
to the presence of RGD-containing peptide in the adhesion 
assay or the presence of EGTA in TSP coating buffer (Fig. 
1 A), as Lawler et al. (1988) described. There was no obvious 
difference between the adhesive and nonadhesive TSP prepa- 
rations in details of  the purification procedure or in immuno- 
blots for fibronectin, fibrinogen, or vitronectin, potential 
contaminants with adhesive activity. Furthermore, the adhe- 
sion of BAE cells to TSP-BR220 was not affected by poly- 
clonal antibody against vitronectin added at an amount that 
abolished the cell attachment to wells coated with 0.2/~g/ml 
vitronectin (data not shown). 
TSP was also purified following Lawler's procedure with 
the modifications described in Materials and Methods and 
by a modification of our standard method using buffers with 
0.3 mM Ca  2+ rather than 0.1 mM Ca  2+. These alternatively 
purified TSPs were adhesive, and cell adhesion was sensitive 
to RGD-containing peptide and to the presence of EGTA in 
the coating buffer (Fig.  1 B).  Although the alternatively 
purified TSP purified by Lawler's method was contaminated 
with fibrinogen (~5 % as estimated by SDS-PAGE  and im- 
munoblotting), polyclonal antibody against fibrinogen did 
not block cell adhesion whereas the same amount of anti- 
body  abolished  cell  adhesion  to  fibrinogen-coated wells 
(data not shown). 
Cys  974 Is the Only Labeled Thiol in Our Purified TSP 
These results suggested that some of the controversies in the 
literature result from differences in TSPs.  The RGD  se- 
quence of TSP is located in the type 3 repeat region (Lawler 
and Hynes,  1986).  This region has multiple Ca2§ 
sites and is rich in cysteine. When TSP in platelet releasate 
Cm,Jro~  +AmMGRGDS  §  CO~L,~J  §  +EGTACoating 
Figure 1. Attachment of BAE cells to TSE A  preparation of TSP 
purified by our standard procedure (A) and TSP purified by an alter- 
native procedure (B) were diluted to 20 #g/ml with HBS/1  mM 
Ca  ~+ (Control) or HBS/1  mM  EGTA (+EGTA Coating),  coated 
on nontissue culture dishes, and assayed for cell adhesive activity 
as described in Materials and Methods. GRGDS was added to some 
wells at a final concentration of 0.4 mM (+0.4 mM GRGDS). The 
cell suspension was added at 50,000 cells/2.1-cm  2 well. The num- 
ber (#) of cells attached to 12% of the area of the well was quanti- 
fied. Bars represent means of triplicate assays, and brackets repre- 
sent standard deviations. 
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Figure 2.  [DTT]- and  [TSP]-dependent BAE cell attachment to 
DTT-treated TSE (A) DTT dose response curve for activity. Squares 
represent results when TSP was coated to wells first (5  #g/ml, 
37~  1 h) and then incubated with DTT in the presence of 2 mM 
Ca  2+ (solid squares) or ED'I'A  (open squares). Circles represent 
results when TSP was treated with DTT first in HBS containing 
2 mM Ca  2+ (solid circles) or EDTA (open circles) and then coated 
on wells at 4~  overnight. The cross (X) represents the result of 
cell attachment to fibronectin coated at 5/~g/ml. (B) [TSP]-depen- 
dent cell attachment. Wells were coated with TSP (37~  1 h) at 
the indicated concentrations and incubated with 20 mM DTT in 
HBS at room temperature for 30 min (open symbols) or with HBS 
without DTT as  control (closed symbol).  In both experiments, 
25,000 cells/well were allowed to attach for 1.5 h at 37~  Each 
point represents mean of triplicate samples, and brackets represent 
standard deviations. 
was analyzed,  12 free cysteines were identified  in the type 
3 repeat region and adjacent carboxyl-terminal globular re- 
gion, although there was a stoichiometry of  one free thiol per 
TSP subunit (Speziale and Detwiler,  1990).  An interpreta- 
tion of these results is that the position of the free thiol may 
vary through thiol-disulfide isomerization so that each of the 
labeled cysteines is a  free thiol in a  small fraction of TSP 
molecules. When our nonadhesive TSP purified in 0.1 mM 
Ca  2§ was labeled with ~4C-iodoacetic acid to derivatize free 
thiols, followed by chymotrypsin digestion and separation of 
peptides by HPLC, only a single peak (>5-fold higher than 
background) was  found to  contain  radio-derivatized thiol 
(peak  19  of VYDAC  C~8  5  /~m  column  and  peak  6  of 
Nucleosil C~8 7-t~m column, data not shown).  Sequencing 
of this  peptide yielded VQTVNCDPGLAVGYDEF, corre- 
sponding to residues 969-985 in TSP (Lawler and Hynes, 
1986).  Thus, only Cys  974  was found to be labeled. 
TSP Reduced with DTT Is Adhesive 
Because our nonadhesive TSP was only labeled at Cys  974, 
we  hypothesized  that  nonadhesive  preparations  of  TSP 
lacked thiol-disulfide isomer(s) in which the RGD adhesive 
sequence is  exposed.  To test this  possibility,  nonadhesive 
TSP was reduced with various concentrations of DTT and 
tested for adhesive activity.  Fig. 2 A shows the DTT dose- 
response curves for cell adhesion. TSP, 5/~g/ml, was either 
coated on the well first then reduced with up to 20 mM DTT 
in the presence of Ca  2§ or EDTA, or reduced first and then 
coated on wells.  Reduction of TSP with DTT by either route 
made  the  TSP adhesive.  The presence  of Ca  2§  or  EDTA 
when TSP was treated with [TI'T significantly changed the 
response to  DTT.  In the  presence  of Ca  2§  generation of 
adhesive activity required 20 mM DTT, whereas in the pres- 
ence of EDTA, activity required only 2 mM DTT. Although 
more cells attached to wells on which TSP was coated first 
and then reduced compared to wells coated with TSP that 
had been incubated with DTT before coating, the response 
patterns to DTT were the same. 
When nonadhesive TSP was precoated and treated with 
DTT at a fixed concentration of 20 mM, cell attachment was 
dependent on the concentration of TSP in the coating buffer 
(Fig.  2 B). Under these conditions, half maximal cell adhe- 
sion was seen in wells coated with  1 #g/ml TSP. 
Cells  were well  spread on DTT-treated TSP (Fig.  3 A) 
compared to those attached to the adhesive TSP (BR220) de- 
scribed above (Fig.  3 B). It should be noted that the concen- 
Figure 3. Spreading of ceils on nonadhesive TSP subsequently treated with DTT as compared to the adhesive preparation of TSE (A) BAE 
cells spread on nonadhesive TSP coated at 6 ~g/ml and then treated with 20 mM DTT in I-IBS  at room temperature for 0.5 h. (B) BAE 
cells attached to adhesive TSP (preparation BR220), coated at 20 t~g/ml. In both cases, TSP was coated at 37~  for 1 h, and cells were 
allowed to attach for 1.5 h at 37~  The attached cells were fixed with paraformaldehyde before photography. Bar, 40/~m. 
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different: nonadhesive TSP was coated at 6 #g/ml before it 
was treated with 20 mM ffI~, whereas adhesive TSP was 
coated at 20 #g/ml, a usual dose described in the literature. 
Treatment of adhesive TSP with DTT caused the TSP to be 
more adhesive so that cells spread as in Fig. 3 A on adhesive 
TSP coated at concentrations of 3 or 10 ~g/ml and then were 
treated with DTT (not shown). 
Adherent cells were viable as judged from their ability to 
exclude trypan blue (data not shown). BAE cells pretreated 
with cycloheximide, 10 #g/ml, spread as well as non-cyclo- 
heximide-treated cells (data not shown). 
Similar results as  those described above for BAE cells 
were obtained when the experiments were done with C32 
melanoma cells (data not shown). 
Cellular Adhesion to  DTT-Reduced TSP 
Is Sensitive to RGD-containing Peptide and a 
Monoclonal Antibody to the 
Vitronectin Receptor 
Cell adhesion to DTT-treated TSP was sensitive to the pres- 
ence of GRGDS peptide: 0.025 mM GRGDS reduced cell 
adhesion to 50 5:6.2 % of control wells in which no peptide 
was added, and 0.1  mM GRGDS reduced to  12  +  4.5%, 
whereas 0.1 mM RGES only slightly reduced the cell adhe- 
sion (85 +  3.2%). These results support the hypothesis that 
the enhanced adhesive activity of DTT-treated TSP is due to 
the exposure of its RGD sequence. 
Inhibition of  adhesion by the RGD-containing peptide sug- 
gests that integrin receptor(s) are  involved.  Lawler et al. 
(1988) and Tuszynski et al. (1989) showed that cellular adhe- 
sion to their adhesive TSP was sensitive to antivitronectin re- 
ceptor (otvB3)  polyclonal or monoclonal antibodies. LM609 
mAb, which recognizes a functional site on intact vitronectin 
receptor and inhibits attachment of endothelial cell to vitro- 
nectin and von Willebrand factor (Cheresh, 1987), was tested 
for its inhibitory effect on the cell adhesion.  LM609,  0.1 
mg/ml, reduced the cell adhesion to 33  +  4.5% of control 
value, while the control mAb 8E6 to vitronectin did not have 
an inhibitory effect (109  +  9.3%). 
Reduction and Derivatization of Cysteines Is Less in 
the Presence of Ca  2+ 
Because the DTT dose response curve for TSP adhesive ac- 
tivity was different in the presence of Ca  2+ than in the pres- 
ence of EDTA, we quantified how the presence of Ca  2+ or 
EDTA influenced the reduction of TSP with increasing con- 
centrations of DTT. To this end, TSP was treated with DTT 
at different concentrations in the presence of 2 mM Ca  2+ or 
EDTA, reacted with iodoacetamide to carboxyamidomethy- 
late free cysteine residues, dialyzed, and subjected to amino 
acid analysis. As shown in Fig. 4, there was a DTT dose- 
dependent  increase  in  content of carboxymethyl-cysteine 
(CM-Cys). The amount of CM-Cys detected in each sample 
is expressed as its ratio to alanine detected in the same sam- 
ple. There was no detectable CM-Cys in samples not treated 
with DTT. The maximum ratio of CM-Cys/Ala obtained was 
1.02 in the presence of EDTA, and 0.59 in the presence of 
2  mM  Ca  2+,  whereas  the  Cys/Ala  ratio  predicted  from 
amino acid sequence is  1.4. 
The DTT-treated and carboxyamidomethylated TSP was 
also  subjected  to  SDS-PAGE  analysis  under  nonreduced 
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with iodoacetamide as described in Materials and Methods. Sam- 
pies were dialyzed against 1% acetic acid,  lyophilized, and sub- 
jected to amino acid analysis. The amount of carboxymethyl-cys- 
teine (CM-Cys) detected in each hydrolysate was normalized by the 
amount of alanine (Ata) in the same sample. 
Figure  4.  Derivatization  of 
carboxymethyl-cysteine,  the 
effect of  [DTT],  Ca  2+,  and 
EDTA. TSP was treated with 
different  concentrations  of 
DTT in the presence of 2 mM 
of  Ca  2+  (open symbols) or 
EDTA (closed symbols). The 
free  cysteine  residues  were 
then carboxyamidomethylated 
conditions (Fig.  5).  TSP derivatized after exposure to <2 
mM  DTT remained trimeric and  moved with  decreasing 
mobility. This was more obvious in samples treated in the 
presence  of  EDTA  than  in  the  presence  of  Ca  2+.  This 
phenomenon suggests  that  in  the  presence of EDTA,  in- 
trachain disulfides in TSP molecule are more vulnerable to 
reduction with DTT. Monomeric subunits were seen in TSP 
derivatized after exposure to >2 mM DTT. After exposure 
to 20 mM DTT, all the TSP was monomeric. The presence 
of Ca  2+ or EI~A did not facilitate or change the production 
of monomer.  Electrophoretic analysis  under  the  reduced 
condition showed no difference between the samples  (not 
shown). 
After dialysis against TBS, there were visible aggregates 
in  the  carboxyamidomethylated TSP  samples,  especially 
in those treated with higher concentrations of DTT and in 
the presence of Ca  2+. Chemical cross-linking with glutaral- 
dehyde confirmed that  most  protein  was  aggregated  (not 
shown). TSP treated with DTT but not carboxyamidomethyl- 
ated also could be cross-linked to multimers, but to a lesser 
extent.  Most probably due to the degree of aggregation, 
fewer cells were attached to wells coated with carboxyamido- 
methylated TSP than to those coated with TSP treated with 
equivalent concentrations of DTT but not carboxyamido- 
methylated and dialyzed (data not shown). 
Cell Blots of  Reduced Proteolytic Fragments of TSP 
Localize the Adhesive Activity to Its RGD-containing 
type 3 Repeat Region 
Cell blots of reduced TSP and its proteolytic fragments were 
performed  to  map  the  DTT-enhanced  adhesive  activity 
within  TSP.  TSP  was  digested  by  thrombin,  trypsin,  or 
chymotrypsin using published conditions that control the ex- 
tension of proteolysis at the carboxyl-terminal end of the 
molecule (Lawler et al.,  1985,  1986). The digestion mix- 
tures were analyzed by SDS-PAGE under reducing condi- 
tions and transferred electrophoretically to nitrocellulose pa- 
per.  The paper was then incubated with BSA to block its 
surface, and with BAE cell suspensions to allow ceils to at- 
tach on proteins that have the adhesive activity. The adherent 
ceils were stained with trypan blue. 
Fig. 6 A shows that cells adhered to intact TSP and 120- 
140-kD thrombin-generated fragments which are known to 
contain the Ca2+-sensitive  type 3 repeat region recognized 
by MA-I mAb in experiments by Lawler et al. (1985,  1986). 
Adherent cells were well-spread and polygonal when viewed 
with a dissecting microscope. Adherence of cells to these 
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treated and carboxyamidomethylated TSP. 
TSP samples, treated with various concen- 
trations of IYFF in the presence of Ca  :+ or 
EDTA and then alkylated  with  iodoacet- 
amide, were electrophoresed on a 5 % poly- 
acrylamide gel with SDS under nonreduced 
condition.  The protein  was  stained  with 
Coomassie blue. 
bands  was  blocked by the  RGD-containing  peptide.  The 
85-kD fragment generated by trypsin digestion in the pres- 
ence of  EDTA, and the 70-kD fragment generated by chymo- 
trypsin digestion in a high enzyme-to-substrate ratio did not 
support cell adhesion. Both fragments did not contain the 
MA-1 epitope in experiments reported by Lawler et al. (1985, 
1986). 
Fig. 6 B shows that, when TSP was digested by trypsin and 
chymotrypsin under conditions that spare the MA-1 epitope, 
the cell blot patterns were changed. Trypsin digestion of TSP 
in the presence of Ca  :§ generates a major 85-kD fragment 
that contains the MA-1 epitope (Lawler et al.,  1985); this 
fragment supported cell adhesion. Chymotrypsin digestion 
of TSP in a  low enzyme-to-substrate ratio generates frag- 
ments in a wide molecular weight range, most containing the 
MA-1 epitope (Lawler et al.,  1986). These same fragments 
also supported cell adhesion. 
To confirm the correlation between the presence of MA-1 
epitope and the cell adhesive activity of the reduced TSP 
fragments, duplicated sample sets were immunoblotted with 
MA-1 mAb. The immunoblot patterns (not shown) were the 
same as those of cell blot pattern. 
Figure 6. Cell blots of  reduced 
TSP fragments. Reduced TSP 
(4 t~g/lane) and the protease 
digestion mixtures (8 #g/lane) 
were separated by SDS-PAGE 
and  then  electrophoretically 
transferred to a nitrocellulose 
paper.  The paper was either 
stained with amido black for a 
permanent  record  of protein 
bands  (protein  staining) or 
stained  temporarily  for pro- 
tein with ponceau S and then 
incubated with BSAJTBS fol- 
lowed by a BAE cell suspen- 
sion (cell blotting). Pen marks 
in the blotting panels indicate 
bands that stained with pon- 
ceau S.  Samples analyzed in 
A; 0, intact TSP; Th, throm- 
bin digest;  Tr,  trypsin  0:20 
wt/wt) digest in 2 mM EDTA, 0*C, 20 h; Ch, ehymotrypsin 0:30 wt/wt) digest in 2 mM EDTA, 37~  20 min. Adhesion of BAE cells 
was performed without (-GRGDS) or with (+GRGDS) 0.4 mM GRGDS in the incubation. Samples analyzed in B: Tr, trypsin (1:5 wt/wt) 
digests in 2 mM Ca  :§  0*C, 24 h; Ch, chymotrypsin 0:5,000 wt/wt) digest in 2 mM EDTA, 0*C, 32 h. The papers for protein staining 
shrunk before photography due to exposure to ethanol and therefore do not line up exactly with the papers for cell blotting. 
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the Proteins Adhesive 
The  "cell  blotting" experiments  indicated that  cells  bind 
specifically to the RGD-containing region of TSP. To test 
specificity further, a number of proteins that do not contain 
RGD were coated on bacteriologic culture dishes at 10 #g/ml 
and treated without or with 20 mM DTT. DTT treatment did 
not enhance cell adhesion to BSA, ovalbumin, goat IgG, hu- 
man  v-globulin,  high  molecular  weight  kininogen,  an- 
tithrombin III, histidine rich glycoprotein, and the amino- 
terminal 70-kD  fragment of fibronectin.  In  contrast,  the 
adhesive activity of bovine thrombin, which has an RGD se- 
quence that supports cell adhesion in certain derivatives of 
thrombin (Bar-Shavit et al., 1991), was enhanced more than 
10-fold by treatment with DTT (data not shown). 
Discussion 
The inconsistencies in the literature about the adhesive activ- 
ity of TSP were reproduced in our experiments. Most prepa- 
rations of our standard TSP did not have RGD-inhibitable 
adhesive activity for trypsinized cells, although these prepa- 
rations  did have heparin-inhibitable  adhesive activity for 
cells that are allowed to recover from trypsinization and thus 
to display cell surface proteoglycans (Kaesberg et al., 1989). 
However, a single preparation of our TSP and TSP purified 
following  alternative  procedures  did  have  the  RGD- 
inhibitable adhesive activity. These findings indicate that at 
least part of the controversies in the literature are due to 
differences in TSPs,  with some TSPs being adhesive and 
some not, and suggest that exposure of the RGD sequence 
in TSP is regulated. 
Because the RGD sequence of TSP is located in the type 
3 repeat region, which contains multiple Ca2+-binding sites 
and  because  TSP  adsorbed  to plastic  in  the  presence  of 
EGTA did not support cell adhesion upon Ca  2§ restoration, 
Lawler et al. (1988) proposed that exposure of the RGD se- 
quence is dependent on Ca  2+. This region of TSP undergoes 
a  major conformational change upon chelation of Ca  ~+ as 
ascertained by rotary shadowing (Lawler et al., 1985; Gal- 
vin et al., 1985; Dixit et al., 1986),  immunological reactiv- 
ity (Dixit et al., 1986),  susceptibility to proteolysis (Lawler 
et al., 1982; Lawler and Simons, 1983; Lawler et al., 1985), 
circular dichroism spectroscopy (Lawler and Simons, 1983), 
electron spin resonance spectroscopy (Slane et al.,  1988), 
and other techniques (Lawler et al., 1982). A Hill plot ofel- 
lipticity versus [Ca  ~+] revealed a Hill coefficient of 12.3, in- 
dicative of a  highly cooperative interaction between ,,o0.1 
and  0.3  mM  Ca  2+  (Lawler and  Simons,  1983).  Possible 
differences between Lawler's TSP purification procedure and 
our standard procedure are Lawler's addition of 2 mM Ca  2+ 
to the platelet suspension before activation by thrombin and 
the  addition  of 2  mM  rather  than  0.1  mM  Ca  2+  to  the 
buffers used in later purification steps. Our platelet releasate 
contained >1  mM Ca  2+ when measured by Ca2+-ion elec- 
trode due to endogenous Ca  2+ released from platelets upon 
activation (Detwiler and Feinman, 1973).  Incubation of our 
nonadhesive TSP with 2 mM Ca  2+ before it was coated on 
plastic  well  did  not make  it adhesive  (data  not  shown). 
Nevertheless, when we used 0.3 rather than 0.1  mM Ca  2§ 
during  all  later  steps,  we  obtained  adhesive  TSP. These 
results  indicate that Ca  2+ preserves  TSP  in  an "adhesive" 
conformation but alone is not sufficient to regulate the ex- 
posure of the RGD sequence. 
Recently, Speziale and Detwiler (1990,  1991) studied the 
number and position of free thiols in freshly secreted platelet 
TSP by derivatization of thiols with radiolabeled N-ethyl- 
maleimide or iodoacetamide, followed by digestion and se- 
quencing of peptides containing derivatized thiols. Although 
there was a stoichiometry of one free thiol per TSP subunit, 
the derivatized cysteine residues were mapped at 12 different 
positions. Of the 12 radiolabeled thiols, 10 were in the type 
3 repeat region, which contains 17 of the total of 69 cysteines 
in each subunit of TSP. The remaining two labeled thiols 
were in the adjacent carboxyl-terminal globular (C-globe) 
region.  The  number of reactive thiols was  a  function of 
[Ca2+]. With increased  [Ca2+], the number of derivatized 
thiols decreased in the same cooperative manner as described 
above for the change in circular dichroism. Thus, the type 3 
repeats the adjacent C-globe region of TSP may participate 
in  a  complex intramolecular thiol-disulfide isomerization 
that is modulated by Ca  2§  In our purified nonadhesive TSP, 
only Cys  TM  in the C-globe region was labeled. These con- 
siderations led us to hypothesize that the nonadhesive TSP 
that we purified was only one of the possible isomers of TSP 
and that the exposure of the RGD sequence in TSP is con- 
trolled by disulfides. To test this hypothesis, TSP was treated 
with reducing agents to break disulfides and tested for its ad- 
hesive activity. Several interesting phenomena were observed. 
First, DTT-treated TSP acted as a potent adhesive mole- 
cule. In previous work when TSP was reported to be adhe- 
sive, it was coated to plastic wells at/>20 #g/ml (Tuszynski 
et al., 1987; Lawler et al., 1988) and supported cell attach- 
ment but not robust cell spreading (Lawler et al., 1988).  In 
contrast, cells were well spread in dishes onto which TSP 
had been coated at concentrations as low as 1 #g/ml and then 
treated with DTT. 
Second, the adhesion of cells to DTT-reduced TSP was in- 
hibited by RGD peptide and sensitive to a mAb which recog- 
nizes a  functional site of the otv/33 vitronectin receptor as 
previously reported (Lawler et al.,  1988). 
Third, the DTT concentrations needed to generate adhe- 
sive activity were  10-fold  higher in the presence of Ca  2§ 
than in the presence of EDTA. Ca  2+ also protected disulfides 
from reduction as ascertained by gel electrophoresis and 
quantification of carboxymethyl-cysteine content after car- 
boxyamidomethylation. Such a protective effect has been ob- 
served previously by Turk and Detwiler (1986) and Speziale 
and Detwiler (1990). 
Finally, cell blots of reduced TSP fragments localized the 
RGD-inhibitable adhesive activity at its Ca2§  and 
RGD-containing type 3 repeat region. 
Our results, together with those by Speziale and Detwiler 
(1990),  strongly suggest that the exposure of RGD sequence 
in TSP is regulated by the disulfide arrangement in its type 
3 repeats and C-globe region. This possibility prompted us 
to analyze closely the amino acid sequence in these regions. 
When amino acid sequence and the homologous alignment 
in the type 3  repeats  were first described by Lawler and 
Hynes  (1986),  residues  were  aligned  into  eight  repeats, 
called 3A and 3B,  to maximize the homology among the 
repeats.  A  Ca2+-binding  loop  sequence  (DXDXDGXXD- 
XXDX or slight modifications thereof) appeared twice in the 
five full type 3A repeats and once in the two partial type 3B 
repeats. This sequence has been noted in several Ca2§  - 
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Figure 7. Alignment of the type 3 repeats and schematic diagram of the type 3 repeat and adjacent C-globe regions. (A) The type 3 repeats 
are aligned according to homologies in the 12 Ca2+-binding loops. (B) The 12 Ca2+-binding loops are numbered. Small circles represent 
the 19 cysteines in the type 3 repeat region and C-globe. Open circles, lightly shaded circles, and heavily shaded circles represent cysteines 
not labeled, lightly labeled, and heavily labeled, respectively, in the experiments of Speziale and Detwiler (1990). Note that the three heavily 
labeled cysteines are in proximity to the RGD adhesive sequence in loop 11. The uncertain arrangements of disulfides in this region of 
TSP are indicated by the question mark for the pairing of Cys-1149 at the extreme carboxyl terminus and are discussed in the text. The 
epitope for MA-1 mapped to a part of TSP carboxyl-terminal to residue 892 in the 10th line when a panel of fusion proteins were tested 
(Lawler and Hynes,  1986). 
ing proteins  (Dang  et al.,  1985).  These proteins adopt a 
characteristic  helix-loop-helix  conformation  (Kretsinger, 
1976; Sudhakar Babu et al.,  1985), with the Ca  2§ bound in 
the loop between the helices. The coordination of Ca  2§ can 
be represented by an octahedron with six vertices. Five ver- 
tices are coordinated with oxygen atoms from side chains, 
and a peptide oxygen coordinates at the sixth (Kretsinger, 
1976,  1980). 
If the 12 loop sequences in this region are aligned, a strik- 
ing pattern emerges (Fig. 7A).  DXDXDGXXDXXDX loop 
sequences are followed six times by a 10-amino acid exten- 
sion, tentatively termed the break sequence. The boundaries 
of both loop and break sequences line up, with the exception 
at line 7, in which the extension of the loop sequence is only 
2 amino acids. The cysteines are aligned either in the loop 
sequence (short lines) or in the break sequence (long lines), 
with the exceptions of lines 3 and 6, in which the cysteines 
are vicinal. The alignment suggests that of the 12 loops, 10 
are in pairs forming 5 loop-loop structures that are followed 
by a break sequence, whereas loops 3 and 6 are separated 
by break sequence after a single loop. 
Inasmuch as there are homologies among the break se- 
quences, it is likely that these sequences share a common 
secondary structure. As pointed out by Lawler et al. (1988), 
the algorithm of Chou and Fasman (1978)  predicts that the 
conserved NPDQ  in the break sequence has a  strong ten- 
dency to form t-turn, with a calculated probability 15-fold 
greater  than  average.  Thus,  we  propose  that  this  entire 
Ca2+-binding  region  is  composed of loop-(loop)-/3-turn- 
repeats (Fig. 7 B). Loop 11, containing the RGD, and loop 
12, as Lawler et al.  (1988) proposed, forms the last of the 
double loop structures followed by the bulky C-globe region. 
Fig. 7 B also shows the relative labeling of cysteines in the 
type 3  repeats and the C-globe region (Speziale and Det- 
wiler, 1990). The cysteines that are fractionally labeled may 
be free or participate in more than one type of disulfide. For 
instance,  Cys  9t2 in loop 11 may form a disulfide with Cys  928 
next to loop 12 or with Cys  892 next to loop 10; Cys  s92 may 
form a  disulfide with Cys  9~2 or with Cys  s76 in loop 9,  etc. 
Cys97L which is the only labeled cysteine in our TSP and is 
replaced by a serine in TSP2 (Lawler et al., 1991), may play 
a  critical  role  in  the  isomerization  either  by  forming  a 
disulfide  with  Cys  H49  or  with  a  cysteine  in  the  type  3 
repeats.  Cys 1149, which is the fourth residue from the car- 
boxy terminus of TSP and is thought to be involved in a 
disulfide (Dixit et al., 1985), may be important in maintain- 
ing the C-globe structure and the exposure of the RGD se- 
quence. One or more of the many potential isomers of TSP 
may have an exposed RGD adhesive sequence and mimic our 
reduced TSP. Such isomers may be only a small percentage 
of the TSP molecules or subunits released from platelets. 
It will be of great interest to identify factors in addition 
to  Ca  2§  and  chemical  reducing  agents  that  modulate  ex- 
posure of the RGD sequence. One possible modifier of TSP 
is  type  V  collagen,  which  interacts  more  strongly  with 
Ca2§  TSP than with Ca2+-replete  TSP (Galvin et 
al.,  1987).  TSP2 has the loop-(loop)-break structure,  the 
RGD sequence in loop 11, and the C-globe (Lawler et al., 
1991). However, there is a serine at 974 rather than cysteine. 
It also will be of interest to learn if TSP2 has a regulated 
RGD or whether this adhesive sequence is constitutively ex- 
posed or constitutively cryptic. 
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